Algoloji Polikliniğine BaĢvuran Onkolojik Hastalarda Tedavi ve Komplikasyon Yönetimi: Retrospektif Değerlendirme
Yükleniyor...
Dosyalar
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
İnönü Üniversitesi Tıp Fakültesi Dergisi
Erişim Hakkı
Özet
Amaç: Bu çalışmada İnönü Üniversitesi Tıp Fakültesi Algoloji Bilim Dalına Ocak 2011-Mart 2012 tarihleri arasında başvuran 241
onkoloji hastasının ağrı şiddeti, uygulanan medikal tedavi yöntemleri, hasta memnuniyeti ve gelişen komplikasyonlar geriye dönük
olarak değerlendirildi.
Gereç ve Yöntemler: Demografik veriler, medikal tedavide kullanılan opioid analjezikler, nöropatik ağrıya yönelik adjuvan tedaviler,
ek hastalıklar, vizüel analog skalagiriş ve kontrol değerleri, kaçak ağrısı, bulantı-kusma, kabızlık, kaşıntı, idrar retansiyonu, sedasyon gibi
yan etkiler ve bunların tedavileri ve hasta memnuniyeti kaydedildi.
Bulgular: Ağrı tedavisi için % 61 zayıf opioid, %9.1 güçlü opioid ve %29.9 zayıf + güçlü opioid kombinasyonu tercih edilmişti.
Nöropatik ağrıya yönelik adjuvan tedavi başlanan 84 (% 35) hastada %47.5 pregabalin, %43.3 amitriptilin, %7.5 gabapentin ve %1,7
gabapentin+amitriptilin kullanıldığı saptandı. Poliklinik başvurusunda ağrı düzeyleri orta ve şiddetli iken (vizüel analog skala bazal
değeri, 7.16 ± 1.5) %90.5 hastada vizüel analog skala kontrol değerinin 4 ve altında olduğu tespit edildi (vizüel analog skalakontrol 3.06
± 1.1). İlaç memnuniyet oranımız %80 iken, bulantı-kusma oranı %30.3, konstipasyon %19.5, sedasyon %19.1, idrar retansiyonu %10
ve kaşıntı %5 idi.
Sonuç: Opioid tedavisindeki tercihlerimiz, başarı oranlarımız ve hasta memnuniyetleri açısından verilerimizin literatür ile uyumlu
olduğu görüldü. Kanser ağrısında iyi planlanmış ağrı protokolleriyle hasta memnuniyet skorlarının yüksek, yan etki insidansının ise
düşük olduğu kanısındayız.
Aim: In thist retrospective study, we evaluated pain intensity, pharmalogical therapy, patient satisfaction and rising complications of 241 oncology patients that applied to Department of Algology outpatient clinic at Inonu University Medicine Faculty, between January 2011 and March 2012. Material and Methods: Demographic data, opioid analgesics in pharmacological therapy, adjuvant therapy for neuropathic pain, additional disease, value of visual analogue scale baseline and visual analogue scale control, breakthrough pain, adverse effects and their treatment such as nausea and vomiting, constipation, pruritis, urine retention, sedation, and patient satisfaction were recorded. Results: Weak opioids (61%), strong opioids (9.1%) and weak+strong opioids combinations (29.9%) had been preferred for pain therapy. It was detected that pregabalin (47.5%), amitriptilin (43.3%), gabapentine (7.5%) and gabapentine-amitiptilin combination (1.7%) were used in 84 (35%) patients for adjuvant therapy in neuropathic pain. As pain levels were modarate and severe (visual analogue scale baseline, 7.16±1.5) in the first application, control visual analogue scale values (visual analogue scale control 3.06±1.1) were 4 and lower than that in 90.5% of the patients. While the rate of satisfaction in therapy was 80%, incidence of nause and vomiting, constipation, sedation, urine retention, and pruritis were 30.3%, 19.5%, 19.1%, 10%, and 5%, respectively. Conclusions: It was revealed that our data were compatible with data in literature about preference of opioid therapy, success rate and satisfaction of patients. We believed that patient satisfaction is high and incidence of adverse effects is low with well planned pain protocols in cancer pain management.
Aim: In thist retrospective study, we evaluated pain intensity, pharmalogical therapy, patient satisfaction and rising complications of 241 oncology patients that applied to Department of Algology outpatient clinic at Inonu University Medicine Faculty, between January 2011 and March 2012. Material and Methods: Demographic data, opioid analgesics in pharmacological therapy, adjuvant therapy for neuropathic pain, additional disease, value of visual analogue scale baseline and visual analogue scale control, breakthrough pain, adverse effects and their treatment such as nausea and vomiting, constipation, pruritis, urine retention, sedation, and patient satisfaction were recorded. Results: Weak opioids (61%), strong opioids (9.1%) and weak+strong opioids combinations (29.9%) had been preferred for pain therapy. It was detected that pregabalin (47.5%), amitriptilin (43.3%), gabapentine (7.5%) and gabapentine-amitiptilin combination (1.7%) were used in 84 (35%) patients for adjuvant therapy in neuropathic pain. As pain levels were modarate and severe (visual analogue scale baseline, 7.16±1.5) in the first application, control visual analogue scale values (visual analogue scale control 3.06±1.1) were 4 and lower than that in 90.5% of the patients. While the rate of satisfaction in therapy was 80%, incidence of nause and vomiting, constipation, sedation, urine retention, and pruritis were 30.3%, 19.5%, 19.1%, 10%, and 5%, respectively. Conclusions: It was revealed that our data were compatible with data in literature about preference of opioid therapy, success rate and satisfaction of patients. We believed that patient satisfaction is high and incidence of adverse effects is low with well planned pain protocols in cancer pain management.
Açıklama
İnönü Üniversitesi Tıp Fakültesi Dergisi, 2013.
Anahtar Kelimeler
Kanser Ağrısı, Ağrı Tedavisi, Komplikasyon, Cancer Pain, Pain Management, Complication
Kaynak
WoS Q Değeri
Scopus Q Değeri
Cilt
Sayı
Künye
Gülay Erdoğan Kayhan, Nurçin Gülhaş, Abdulvahap Aslan, Mahmut Durmuş.(2013).İnönü Üniversitesi Tıp Fakültesi Dergisi.2013:20(1):50-54
